Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 2.5% | 1.6% | 9.1pp | 4 of 40 | 18 |
| EPSEPS | 0.1% | 14.9% | 61.4pp | 14 of 40 | 14 |
| Op cash flowOperating cash flow | 8.6% | -19.1% | 66.1pp | 12 of 40 | 20 |
| EBITDAEBITDA | -3.8% | 1.5% | 57.5pp | 12 of 40 | 16 |
| FCFFree cash flow | 9.1% | -23.1% | 70.3pp | 12 of 40 | 20 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: HCSG on the compounders surface · All compounders, ranked